Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. . Monitored S. 3799, PREVENT Pandemics Act. S. 4348, FDASLA Act of 2022 and H.R. 7667, Food and Drug Amendments of 2022. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to pandemic preparedness and Food and Drug Administration changes. Monitored implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to corporate taxes. Monitored H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023; H.R. 1304, the American Innovation and R&D Competitiveness Act; S. 749, the American Innovation and Jobs Act; and issues related to the R&D tax credit. Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 5376 (P.L. 117-169), the Inflation Reduction Act. Issues related to safe mobility, including H.Res. 1177. Monitored H.R. 7053/S. 3792, The Hospital Inpatient Services Modernization Act and issues related to extension of the acute hospital care at home program. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to the extension of the Acute Hospital Care at Home program.
HCR - Health Issues TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR BRETT BAKER RACHEL JONES HENSLER MARY BETH SAVARY TAYLOR GREG D'ANGELO BRETT BAKER